MicrOmics Technologies Celebrates Successful Completion of SBIR Phase I Project

September 20, 2022

MicrOmics Technologies, a prominent figure in the realm of proteomics, proudly announces the successful completion of its project, funded by a $400,000 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute.

Under the dedicated leadership of Dr. Ryan Kelly, Chief Scientist and Owner of the Utah County-based start-up, MicrOmics Technologies has successfully developed an integrated platform for comprehensive single-cell proteomics. This groundbreaking platform adeptly handles both sample processing and autosampling of single cells in nanoliter volumes, ensuring thorough and unbiased proteome measurements.

MicrOmics Technologies expresses its gratitude to the Utah Innovation Center, which played a crucial advisory role throughout the proposal stage, ultimately leading to the Phase I project win. With this significant achievement under its belt, MicrOmics Technologies now stands in a favorable position to vie for a substantial Phase II contract, adding another potential feather to its cap.

For more details, interested parties can reach out to:

Email: info@micromicstech.com Phone: 509-987-5656

Website: https://www.micromicstech.com/